The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
Trump national security blueprint declares ‘era of mass migration is over,’ targets China’s rise
Mandela Barnes jumps into Wisconsin governor race — but baggage from his 2022 Senate bid follows
Trump administration balances US support for Saudi Arabia and Israel
New Utah map could leave four House GOP members scrambling for three seats
Tom Stoppard, 1937-2025
CBS Continues Overhaul Under Bari Weiss, as Key Anchor Goes ‘Rogue’: Report
Young Americans Are Getting Absolutely Fed Up with the American Duopoly: Poll
Trump taps new architect to reshape White House as $300M ballroom build accelerates
Tom Homan fumes at protester who called him racist during clash at TPUSA event: ‘Grow a backbone’
Mamdani breaks with Adams, vows NYC will stop clearing homeless encampments in January
Arkansas county jail becomes major ICE pipeline as arrests surge under Trump crackdown
Mamdani says NYPD commissioner apologized after her brother called him ‘enemy’ of the Jewish people at gala
Harvard professor detained by ICE after Boston synagogue shooting, agrees to voluntarily leave US
Democrats’ anger at federal government hit record high just days before shutdown: Pew poll
DHS arrests dozens of illegal immigrants within 24 hours of launching New Orleans operation
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
Trump national security blueprint declares ‘era of mass migration is over,’ targets China’s rise
Mandela Barnes jumps into Wisconsin governor race — but baggage from his 2022 Senate bid follows
Trump administration balances US support for Saudi Arabia and Israel
New Utah map could leave four House GOP members scrambling for three seats
Tom Stoppard, 1937-2025
CBS Continues Overhaul Under Bari Weiss, as Key Anchor Goes ‘Rogue’: Report
Young Americans Are Getting Absolutely Fed Up with the American Duopoly: Poll
Trump taps new architect to reshape White House as $300M ballroom build accelerates
Tom Homan fumes at protester who called him racist during clash at TPUSA event: ‘Grow a backbone’
Mamdani breaks with Adams, vows NYC will stop clearing homeless encampments in January
Arkansas county jail becomes major ICE pipeline as arrests surge under Trump crackdown
Mamdani says NYPD commissioner apologized after her brother called him ‘enemy’ of the Jewish people at gala
Harvard professor detained by ICE after Boston synagogue shooting, agrees to voluntarily leave US
Democrats’ anger at federal government hit record high just days before shutdown: Pew poll
DHS arrests dozens of illegal immigrants within 24 hours of launching New Orleans operation
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
